{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:08:03Z","timestamp":1793506083249,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.anndiagpath.2022.151899","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T10:34:56Z","timestamp":1642156496000},"page":"151899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["FISH analyses for 1p and 19q status on gliomas: Reporting an 8\u00a0years' experience from a tertiary care center in the Middle East"],"prefix":"10.1016","volume":"57","author":[{"given":"Elie","family":"Massaad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer","family":"Tabbarah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamdouha","family":"Barmada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Rbeiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selim","family":"Nasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Farra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.anndiagpath.2022.151899_bb0005","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41582-019-0220-2","article-title":"Genetic and molecular epidemiology of adult diffuse glioma","volume":"15","author":"Molinaro","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"26","key":"10.1016\/j.anndiagpath.2022.151899_bb0010","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","article-title":"Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas","volume":"372","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.anndiagpath.2022.151899_bb0015","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol (Berl)"},{"issue":"suppl_4","key":"10.1016\/j.anndiagpath.2022.151899_bb0020","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011\u20132015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro-Oncol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2022.151899_bb0025","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S1474-4422(18)30468-X","article-title":"Global, regional, and national burden of brain and other CNS cancer, 1990\u20132016: a systematic analysis for the global burden of disease study 2016","volume":"18","author":"Patel","year":"2019","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2022.151899_bb0030","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/01.jnen.0000235122.98052.8f","article-title":"Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss","volume":"65","author":"Griffin","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2022.151899_bb0035","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2217\/cns.15.28","article-title":"Molecular diagnostics: techniques and recommendations for 1p\/19q assessment","volume":"4","author":"Woehrer","year":"2015","journal-title":"CNS Oncol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2022.151899_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.pdm.0000138207.96718.85","article-title":"Molecular diagnostic techniques for the clinical evaluation of gliomas","volume":"14","author":"Kelley","year":"2005","journal-title":"Diagn Mol Pathol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2022.151899_bb0045","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/nan.12031","article-title":"1p\/19q testing has no significance in the workup of glioblastomas: 1p\/19q codeletion in glioblastomas","volume":"39","author":"Clark","year":"2013","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2022.151899_bb0050","first-page":"1175","article-title":"Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p","volume":"145","author":"Reifenberger","year":"1994","journal-title":"Am J Pathol"},{"issue":"19","key":"10.1016\/j.anndiagpath.2022.151899_bb0055","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/jnci\/90.19.1473","article-title":"Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas","volume":"90","author":"Cairncross","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.anndiagpath.2022.151899_bb0060","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1200\/JCO.2000.18.3.636","article-title":"Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas","volume":"18","author":"Smith","year":"2000","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1016\/j.anndiagpath.2022.151899_bb0065","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1200\/JCO.2017.72.6737","article-title":"Diffuse infiltrating oligodendroglioma and astrocytoma","volume":"35","author":"van den Bent","year":"2017","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2022.151899_bb0070","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jmoldx.2016.06.002","article-title":"Diagnostic detection of allelic losses and imbalances by next-generation sequencing","volume":"18","author":"Dubbink","year":"2016","journal-title":"J Mol Diagn"},{"issue":"12","key":"10.1016\/j.anndiagpath.2022.151899_bb0075","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/neuonc\/nos263","article-title":"Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese glioma cooperative group","volume":"14","author":"Yan","year":"2012","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.anndiagpath.2022.151899_bb0080","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jocn.2018.05.002","article-title":"Ten-year survival in glioblastoma.A systematic review","volume":"54","author":"Tykocki","year":"2018","journal-title":"J Clin Neurosci."},{"issue":"6","key":"10.1016\/j.anndiagpath.2022.151899_bb0085","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00401-015-1432-1","article-title":"Glioblastoma: pathology, molecular mechanisms and markers","volume":"129","author":"Aldape","year":"2015","journal-title":"Acta Neuropathol (Berl)"},{"issue":"3","key":"10.1016\/j.anndiagpath.2022.151899_bb0090","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10014-011-0038-0","article-title":"Loss of heterozygosity analysis in malignant gliomas","volume":"28","author":"Mizoguchi","year":"2011","journal-title":"Brain Tumor Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2022.151899_bb0095","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/neuonc\/not145","article-title":"Loss of heterozygosity 1p\/19q and survival in glioma: a meta-analysis","volume":"16","author":"Zhao","year":"2014","journal-title":"Neuro-Oncology"},{"issue":"4","key":"10.1016\/j.anndiagpath.2022.151899_bb0100","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/bpa.12018","article-title":"Glioblastoma with oligodendroglioma component (GBM-O): molecular genetic and clinical characteristics: molecular and clinical characteristics of GBM-O","volume":"23","author":"Appin","year":"2013","journal-title":"Brain Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2022.151899_bb0105","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11060-009-9815-6","article-title":"Cerebral glioblastoma with oligodendrogliomal component: analysis of 36 cases","volume":"94","author":"Salvati","year":"2009","journal-title":"J Neurooncol"},{"key":"10.1016\/j.anndiagpath.2022.151899_bb0110","doi-asserted-by":"crossref","DOI":"10.4137\/BMI.S9003","article-title":"Detection of 1p19q deletion by real-time comparative quantitative PCR","volume":"7","author":"Chaturbedi","year":"2012","journal-title":"Biomark Insights"},{"issue":"4","key":"10.1016\/j.anndiagpath.2022.151899_bb0115","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.path.2012.09.001","article-title":"Something old and something new about molecular diagnostics in gliomas","volume":"5","author":"Horbinski","year":"2012","journal-title":"Surg Pathol Clin"},{"issue":"7","key":"10.1016\/j.anndiagpath.2022.151899_bb0120","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/neuonc\/nop075","article-title":"Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses\u2020","volume":"12","author":"Vogazianou","year":"2010","journal-title":"Neuro-Oncol."},{"issue":"5","key":"10.1016\/j.anndiagpath.2022.151899_bb0125","doi-asserted-by":"crossref","first-page":"558","DOI":"10.5858\/2010-0649-RAIR.1","article-title":"Molecular diagnostics of gliomas","volume":"135","author":"Nikiforova","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.anndiagpath.2022.151899_bb0130","series-title":"Current protocols in molecular biology","article-title":"Overview of DNA microarrays: types, applications, and their future","author":"Bumgarner","year":"2013"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913422000016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913422000016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:34:32Z","timestamp":1761078872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913422000016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":26,"alternative-id":["S1092913422000016"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2022.151899","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FISH analyses for 1p and 19q status on gliomas: Reporting an 8\u00a0years' experience from a tertiary care center in the Middle East","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2022.151899","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151899"}}